Susceptibility of staphylococci and enterococci to antimicrobial agents at different ward levels in four north European countries

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 11-12, 2007, Pages 1002-1012

  Claesson, Carina ^a   Hällgren, Anita ^a   Nilsson, Maud ^a   Svensson, Erik ^b   Hanberger, Håkan ^a   Nilsson, Lennart ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CLINDAMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MOXIFLOXACIN; OXACILLIN; RIFAMPICIN; SULFAMETHOXAZOLE; TEICOPLANIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL TRIAL; DENMARK; DRUG RESISTANCE; DRUG SENSITIVITY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FINLAND; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; MULTICENTER STUDY; NORWAY; PREVALENCE; PRIMARY MEDICAL CARE; STAPHYLOCOCCUS; SWEDEN; WARD;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; EUROPE; HOSPITAL UNITS; HOSPITALS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS;

EID: 36348978660     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701472064     Document Type: Article

References (32)

1. Hanberger, H., Monnet, DL and Nilsson, LE (2004) Antibiotic Policies: Theory and Practice, pp. 261-279. Kluwer Academic/Plenum Publisher, New York
2. Fridkin, SK, Steward, CD, Edwards, JR, Pryor, ER, McGowan Jr, JE and Archibald, LK (1999) FC and Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Hospitals. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Clin Infect Dis, 29, pp. 245-252.
3. Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. and Tenover, FC. (1997) Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Correspondence. J Antimicrob Chemother, 40, pp. 135-136.
4. Fitch, L. and Johnson, AP. (1998) Reduced susceptibility to teicoplanin in a methicillin resistant strain of Staphylococcus aureus. Correspondence. J Antimicrob Chemother, 41, p. 578.
5. Price, MF, McBride, ME and Wolf Jr, JE (1998) Prevalence of methicillin resistant Staphylococcus aureus in a dermatology outpatient population. South Med J, 91, pp. 369-371.
6. Hsu, J., Lanza, DC and Kennedy, DW. (1998) Antimicrobial resistance in bacterial chronic sinusitis. Am J Rhinol, 12, pp. 243-248.
7. Simonsen, GS, Småbrekke, L., Monnet, DL, Sørensen, TL, Müller, JK and Kristinsson, KG (2003) Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in 5 Nordic hospitals. J Antimicrob Chemother, 51, pp. 323-331.
8. Barisic, Z. and Punda-Polic, V. (2000) Antibiotic resistance among enterococcal strains isolated from clinical specimens. Short communication. Int J Antimicrob Agents, 16, pp. 65-68.
9. Walsh, TR, Bolmström, A., Qwärnström, A., Wooton, M. and Howe, RA (2001) Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol, 39, pp. 2439-2444.
10. Enterococci. E-test application sheet EAS 009 [online] 2005-05 [cited 2006 July 19].
11. SRGA: MIC breakpoints from SRGA [online] 2006 April 20 [cited 2006 April 26].
12. EUCAST clinical MIC breakpoints [online] 2006 January 31 and March 31 [cited 2006 April 12].
13. Hanberger, H., Hoffmann, M., Lindgren, S. and Nilsson, LE. (1997) High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden. Scand J Infect Dis, 29, pp. 607-614.
14. Erlandsson, C-M, Hanberger, H., Eliasson, I., Hoffmann, M., Isaksson, B., Lindgren, S. and in the ICU study group of south-east Sweden (1999) Surveillance of antibiotic resistance in ICUs in south-east Sweden. Acta Anaesthesiol Scand, 43, pp. 815-820.
15. Hanberger, H., Diekema, D., Fluit, A., Jones, R., Struelens, M., Spencer, R. and Wolff, M. (2001) Surveillance of antibiotic resistance in European ICUs. J Hosp Infect, 48, pp. 161-176.
16. Von Eiff, C. and Peters, G. (1999) Comparative in vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci. J Antimicrob Chemother, 43, pp. 569-573.
17. Diekema, DJ, Pfaller, MA, Schmitz, FJ, Smayevsky, J., Bell, J., Jones, RN, Beach, M. and the SENTRY participants group (2001) Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific region for the SENTRY antimicrobial surveillance programme, 1997-1998. Clin Infect Dis, 32, pp. 114-132.
18. Agvald-Öhman, C., Lund, B., Hjelmqvist, H., Hedin, G., Struwe, J. and Edlund, C. (2006) ICU stay promotes enrichment and dissemination of multiresistant coagulase negative staphylococcal strains. Scand J Infect Dis, 38, pp. 441-447.
19. May, J., Shannon, K., King, A. and French, G. (1998) Glycopeptide tolerance in Staphylococcus aureus. J Antimicrob Chemother, 42, pp. 189-197.
20. Bobin-Dubreux, S., Reverdy, M-E, Nervi, C., Rougier, M., Bolmström, A., Vandenesch, F. and Etienne, J. (2001) Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative. Antimicrob Agents Chemother, 45, pp. 349-352.
21. Del'Almo, L., Cereda, RF, Tosin, I., Miranda, EA and Sader, HS. (1999) Antimicrobial susceptibility of coagulase negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Diagn Microbiol Infect Dis, 34, pp. 185-191.
22. Cercenado, E., García-Leoni, ME, Díaz, MD, Sánchez-Carrillo, C., Catalän, P., de Quirós, JCL Bernaldo and Bouza, E. (1996) Emergence of teicoplanin-resistant coagulase negative staphylococci. J Clin Microbiol, 34, pp. 1765-1768.
23. Woodford, N., Johnson, AP, Morrison, D. and Speller, DC. (1995) Current perspectives on glycopeptide resistance. Clin Microbiol Rev, 8, pp. 585-615.
24. Chomarat, M., Espinouse, D. and Flandrois, J-P. (1991) Coagulase negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity. J Antimicrob Chemother, 27, pp. 475-480.
25. Bertin, M., Muller, A., Bertrand, X., Cornette, C., Thouverez, M. and Talon, D. (2004) Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase negative staphylococci. Eur J Clin Microbiol Infect Dis, 23, pp. 375-379.
26. Scouthen, MA, Hoogkamp-Korstanje, JAA, Meis, JFG, Voss, A. and the European VRE Study Group (2000) Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis, 19, pp. 816-822.
27. Torell, E., Köhn, I., Olsson-Liljequist, B., Haeggman, S., Hoffman, B-M, Lindahl, C. and Burman, LG. (2003) Clonality among ampicillin-resistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance. Clin Microbiol Infect, 9, pp. 1011-1019.
28. Jureen, R., Top, J., Mohn, SC, Harthug, S., Langeland, N. and Willems, RJL. (2003) Molecular characterization of ampicillin-resistant Enterococcus faecium isolates from hospitalized patients in Norway. J Clin Microbiol, 41, pp. 2330-2336.
29. Leavis, HL, Bonten, MJM and Willems, RJL. (2006) Identification of high-risk enterococcal clonal complexes: Global dispersion and antibiotic resistance. Curr Opin Microbiol, 9, pp. 454-460.
30. EARSS: The EARSS annual report 2005 [online] 2006 Oct [cited 2007 Feb 27].
31. Johnson, AP, Warner, M., Woodford, N., Speller, DCE and Livermore, DM. (1998) Antibiotic resistance among enterococci causing endocardidtis in the UK: Analysis of isolates referred to a reference laboratory. Paper. Br Med J, 317, pp. 629-630.
32. Hällgren, A., Abednazari, H., Ekdahl, C., Hanberger, H., Nilsson, M., Samuelsson, A. and the Swedish ICU Study Group (2001) Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems. J Antimicrob Chemother, 48, pp. 53-62.